Madison Street Capital LLC

07/22/2026 | Press release | Distributed by Public on 07/22/2026 02:32

Market Report: Lower Middle Market M&A- H1 2026 Review & Second-Half Outlook

Market Report

Lower Middle Market M&A

H1 2026 Review & Second-Half Outlook
Madison Street Capital July 2026
The Headline

Executive summary

1

The market is stabilizing

After a prolonged slowdown, capital is concentrating in fewer, larger, higher-conviction deals. Aggregate deal value rose in the first half even as transaction counts stayed disciplined.

2

Valuations are holding firm

EV/EBITDA multiples held their range, scaling with size, from roughly 6.4x for smaller businesses to 8x+ for those with $10M+ in EBITDA. Consensus points to multiples staying flat through 2026.

3

Capital is abundant, but selective

Private equity is sitting on substantial dry powder, yet buyers are disciplined: a more discerning market beneath the top tier that rewards clean, scalable businesses and reprices uncertainty.

4

A constructive setup for H2

Anticipated further rate cuts, mounting deployment pressure, and a selectively reopening exit window point to steady re-acceleration into the back half of the year.

H1 2026 at a glance

By the numbers

~8.1x
EV/EBITDA for lower middle market businesses with $10M+ in EBITDA
~7.2x
Average purchase multiple for sponsored LBOs, $10-500M enterprise value
$36.5B
Medtech M&A deal value in the first half of 2026
+10%
Rise in aggregate PE deal value in H1 2026, as capital concentrated in larger deals
Sources: GF Data (multiples, H1 2025 baseline into 2026); PwC Global M&A trends, 2026 mid-year outlook.
Activity

Fewer, larger, higher-conviction deals

U.S. private equity, H1 2026 vs. H1 2025 (2025 = 100)
100
33
110
Deal count
Aggregate value

Fewer, higher-conviction deals

Buyers are concentrating capital on the assets they want most and passing on the rest: a more discerning market beneath the top tier.

Larger deals are returning

Even with lower transaction counts, aggregate deal value rose, lifted by a return of megadeal and platform activity.

A flight to quality

Clean, scalable businesses with clear strategic fit are drawing the competition, while uncertainty is repriced or passed over.

Source: PwC US Deals 2026 mid-year outlook (U.S. private equity, H1 2026 vs. H1 2025).
Pricing

Valuations: steady, with a widening quality premium

EV/EBITDA by size band (x)
6.4x
7.2x
8.1x
$3-5M EBITDA
Sponsored LBO avg
$10M+ EBITDA

Multiples scale sharply with size and quality: bigger, cleaner earnings streams command a meaningful premium, rewarding sellers who come to market well-prepared.

2026 consensus
Flat

Bain, McKinsey, Lincoln International, and GF Data all expect multiples to hold near current levels through 2026, steady footing for owners weighing their timing.

Sources: GF Data (size-band multiples, H1 2025 baseline); 2026 multiples consensus per Bain, McKinsey, Lincoln International, GF Data.
Conditions

Financing & buyer behavior

$

Rates elevated but easing

Financing costs remain higher than the last cycle, but anticipated further cuts are improving the outlook. Leverage is being structured more conservatively than in the cheap-debt era.

12

"12 is the new 5"

With cheap leverage gone, sponsors now need roughly 10-12% annual EBITDA growth to generate the returns that 5% growth delivered when multiples were expanding, putting a premium on genuine value creation.

The quality premium is widening

Clean, scalable, recurring-revenue businesses clear quickly and at full value. Assets with customer concentration or earnings volatility face longer processes and wider bid-ask gaps.

Add-ons are doing the work

A large share of activity is corporate and PE-backed add-ons: buyers building scale through bolt-ons rather than paying up for new platforms.

Sources: GF Data; PwC 2026 mid-year Deals outlook.
Sector deep-dive · 1 of 3

Healthcare: value up sharply, buyers more selective

Health services M&A deal value ($B)
$9B
$18B
$8B
$11B
Q1
Q2
2025
2026

Deal value roughly doubled YoY

Health services deal value reached $18B in Q1 and $11B in Q2 2026, up from $9B and $8B a year earlier, even as deal count grew more selective.

Reimbursement uncertainty is the brake

Volume beneath the megadeals softened as investors weighed policy and reimbursement risk, favoring assets that can scale without heavy labor-cost growth.

Where capital is flowing

Buyers prize strong margin profiles, scalable operations, and measurable performance upside. Medtech was especially active at $36.5B in H1 2026.

Sources: PwC Global M&A trends in health industries, 2026 mid-year outlook; J.P. Morgan; Baker Tilly.
Sector deep-dive · 2 of 3

Industrials & construction services

1

Stable cash flows in demand

Private equity is concentrating on mid-market industrials with stable cash flows and scalable models, exactly the profile that clears in a selective market.

2

Construction & engineering momentum

Construction services and architecture & engineering are among the segments attracting the strongest financial-buyer interest heading into H2.

3

Structural tailwinds

Infrastructure investment and reshoring continue to underpin demand, supporting both organic growth and acquisition appetite.

4

Consolidation of fragmented trades

Highly fragmented specialty-trade and services niches are prime roll-up territory, with platforms actively pursuing bolt-ons.

Sources: PwC 2026 mid-year outlook; industry sources.
Sector deep-dive · 3 of 3

Business services

1

Recurring revenue commands a premium

Tech-enabled services with sticky customer relationships and recurring revenue remain the most sought-after profile: recurring income mitigates risk in an uncertain market.

2

Segments drawing the strongest interest

Accounting, HR & staffing, healthcare IT services, and architecture & engineering all gained transaction momentum with financial buyers.

3

Resilience through the cycle

Non-cyclical, contract-based services offer the stability buyers prize in an uncertain macro backdrop, keeping quality assets competitive.

4

Roll-ups in full swing

Buyers continue to build scale through add-ons, favoring platforms with proven, repeatable integration playbooks.

Sources: PwC 2026 mid-year outlook; J.P. Morgan; industry sources.
The road ahead

Second-half 2026 outlook

Tailwinds

  • Anticipated further interest-rate cuts easing financing costs
  • Substantial PE dry powder under pressure to deploy
  • IPO and exit windows selectively reopening
  • Valuations stabilizing, restoring seller confidence
  • Strategic acquirers carrying healthy balance sheets

Headwinds

  • Exit activity still suppressed; secondaries as the release valve
  • Fundraising pressure as LP expectations meet 2026 reality
  • Geopolitical tension and sticky inflation on input costs
  • Policy and reimbursement uncertainty in healthcare
  • Persistent bid-ask gaps on lower-quality assets
Base case: a steady re-acceleration through year-end, provided inflation and geopolitics stay contained.
Implications

What it means for business owners

A real window is open

Pricing is steady and disciplined buyers are actively hunting quality. For well-positioned owners, conditions are the most constructive in over a year.

Preparation is the differentiator

The widening quality premium rewards clean financials, scalable operations, and a clear growth story. The gap between a prepared and unprepared process has never been wider.

Positioning beats timing

In a selective market, how a business is packaged and taken to market drives outcomes as much as when. Competitive tension is what converts interest into premium value.

Madison Street Capital helps owners understand what their business is worth, shape the right go-to-market strategy, and run a disciplined process, at no cost until a decision to sell is made.
Let's talk

Considering your options?

We're glad to orient you on the market and what your business could command: no obligation, no pressure.

Madison Street Capital
901 S. Mopac Expressway, Bldg 1 #300, Austin, TX 78746
312 529 7000 · www.madisonstreetcapital.com
This report is for informational purposes only and does not constitute investment, legal, or tax advice, or an offer or solicitation. Figures are drawn from third-party sources believed reliable (GF Data, PwC, J.P. Morgan, Baker Tilly) covering H1 2026; accuracy is not guaranteed and market conditions change.
Madison Street Capital LLC published this content on July 22, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 22, 2026 at 08:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]